TITLE

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

AUTHOR(S)
Harrison, S. A.; Oliver, D.; Arnold, H. L.; Gogia, S.; Neuschwander-Tetri, B. A.
PUB. DATE
October 2008
SOURCE
Gut;Oct2008, Vol. 57 Issue 10, p1441
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Clinical predictors of advanced non-alcoholic liver disease (NAFLD) are needed to guide diagnostic evaluation and treatment. Methods: To better understand the demographics of NAFLD and risk factors for advanced disease, this study analysed 827 patients with NAFLD at two geographically separate tertiary medical centres. Results: The cohort was 51% female and had a median body mass index (BMI) of 33 kg/m2 3% had a normal BMI. Common co-morbidities included hypertension (60%) and diabetes (35%); insulin resistance was present in 91% and advanced fibrosis in 24% of patients. When comparing patients with no fibrosis or mild fibrosis to those with advanced fibrosis, BMI ⩾ 28 kg/m2, age >50 years, and aspartate transarninase/alanine amino-transferase (AST/ALT) ratio ⩾0.8, a quantitative assessment check index (QUICKI) score <0.294 (equivalent to horneostatasis model assessment (HOMA) >6.2) and the presence of diabetes mellitus (OM) were individually associated by univariate analysis with odds ratios (ORs) of ⩾2.4 for advanced fibrosis. Based on the results of forced entry logistic regression analysis, three variables were combined in a weighted sum (BMI ⩾28 = 1 point, AAR of ⩾0.8 = 2 points, DM = 1 point) to form an easily calculated composite score for predicting advanced fibrosis called the BARD score. A score of 2-4 was associated with an OR for advanced fibrosis of 17 (confidence interval 9.2 to 31.9) and a negative predictive value of 96%. Conclusions: Insulin resistance and its co-morbidities are often present in patients with NAFLD. An easily calculated score based on readily available clinical data can reliably exclude the presence of advanced fibrosis in these patients, particularly among non-diabetics.
ACCESSION #
34640829

 

Related Articles

  • CASE FATALITY AND MORBIDITY IN PATIENTS WITH ALCOHOLIC LIVER DISEASE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA88 

    Alcoholic liver disease (ALD) is a heterogenous condition, in terms of its presentation, clinical course, and mortality. Available data on mortality at the national level show a rising trend in Great Britain in the face of a steady fall in many other European countries. A study was carried out...

  • LIVER IRON GRADE IN DECOMPENSATED ALCOHOLIC LIVER DISEASE: PROGNOSTIC SIGNIFICANCE AND RELATION TO HFE GENOTYPE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA88 

    Moderate liver iron accumulation is common in alcoholic liver disease (ALD). Its causation is poorly understood but it has been associated with a poor outlook. 0, 1, 2, 3, and 4 iron was found in 41, 20, 12, 5, and 0 of the 78 patients respectively. Iron was seen in hepatocytes in 34 patients,...

  • CLINICAL PROFILE OF CASES OF ALCOHOLIC LIVER DISEASE. Suthar, Hemang; Suthar, Kaushal; Mewada, Bhavna // International Journal of Medical Science & Public Health;2013, Vol. 2 Issue 2, p394 

    Background: Alcohol is most common substance abused. Alcoholic liver disease is a major health care problem in India. Alcohol consumption is directly associated with liver disease mortality and accounts for increased social and economic costs. Alcoholic liver disease may take the forms of acute...

  • Alcoholic Hepatitis . Helman, Richard A.; Temko, Michael H.; Nye, Sylvanus W.; Fallon, Harold J. // Annals of Internal Medicine;Mar71, Vol. 74 Issue 3, p311 

    Provides information on a number of patients with acute alcoholic hepatitis documented by liver biopsy during the healing phase. Effect of prednisolone therapy on the course and survival rate of patients with alcoholic hepatitis; Patient grouping for clinical severity of disease; Symptoms and...

  • Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography. Zhang, Dakun; Li, Peng; Chen, Min; Liu, Liping; Liu, Yang; Zhao, Yuanyuan; Wang, Ruifang // Abdominal Imaging;Apr2015, Vol. 40 Issue 4, p723 

    Objectives: To investigate the diagnostic performance of the acoustic radiation force impulse (ARFI) elastography for the assessment of the liver fibrosis in alcoholic liver disease (ALD). Methods: We included 112 patients with ALD in whom liver biopsy, ARFI elastography, and...

  • Liquid assets. Mayer, Chris; Houghton, Graham; Cowell, Roger; Scullion, Jane // Nursing Standard;11/16/2005, Vol. 20 Issue 10, p30 

    Presents letters to the editor regarding readers opinion on liver transplants to an alcoholic patients. "Most People Will Quit If the Alternative Is Death," comments on the negative scenario poses by the message regarding alcoholism; "Patients Must Show a Clear Commitments," focuses on the...

  • Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease. Petrasek, Jan; Mandrekar, Pranoti; Szabo, Gyongyi // Gastroenterology Research & Practice;2010, Vol. 2010, p1 

    In the multifactorial pathophysiology of alcoholic liver disease (ALD), inflammatory cascade activation plays a central role. Recent studies demonstrated that Toll-like Receptors, the sensors of microbial and endogenous danger signals, are expressed and activated in innate immune cells as well...

  • Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non- alcoholic fatly liver disease. Svegliati-Baroni, G.; Bugianesi, E.; Bouserhal, T.; Marini, F.; Ridolfi, F.; Tarsetti, F.; Ancarani, F.; Petrelli, E.; Peruzzi, E.; Lo Cascio, M.; Rizzetto, M.; Marchesini, G.; Benedetti, A. // Gut;Sep2007, Vol. 56 Issue 9, p1296 

    Background: Insulin resistance is a significant risk factor for hepatic fibrosis in patients with both non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C (CHC), either directly or by favouring hepatic steatosis. Several methods are available to assess insulin resistance, but their...

  • Glucocorticoids plus N-Acetylcysteine in Alcoholic Hepatitis.  // New England Journal of Medicine;2/2/2012, Vol. 366 Issue 5, p476 

    The article presents a study on whether combination therapy with glucocorticoids plus N-acetylcysteine would improve the survival of alcoholic hepatitis patients. The researchers assigned 174 patients randomly to receive prednisolone and N-acetylcysteine or only prednisolone. They found that the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics